Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 178,080 shares at $1.90 ($350K) on 2016-05-31, disclosed to the SEC on 2016-06-02.
Open-market sale of $350k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.90 | 18,110 | $34K | 9.8% |
| 2 | $1.91 | 1,890 | $4K | 1.0% |
| 3 | $1.91 | 1,890 | $4K | 1.0% |
| 4 | $1.92 | 19,700 | $38K | 10.8% |
| 5 | $1.92 | 300 | $576 | 0.2% |
| 6 | $1.92 | 300 |
| $576 |
| 0.2% |
| 7 | $1.93 | 23,837 | $46K | 13.1% |
| 8 | $1.93 | 600 | $1K | 0.3% |
| 9 | $1.93 | 100 | $193 | 0.1% |
| 10 | $1.93 | 100 | $193 | 0.1% |
| 11 | $1.93 | 600 | $1K | 0.3% |
| 12 | $1.94 | 300 | $581 | 0.2% |
| 13 | $1.94 | 300 | $582 | 0.2% |
| 14 | $1.94 | 56,954 | $110K | 31.5% |
| 15 | $1.95 | 790 | $2K | 0.4% |
| 16 | $1.95 | 6,755 | $13K | 3.8% |
| 17 | $1.95 | 790 | $2K | 0.4% |
| 18 | $2.00 | 4,800 | $10K | 2.7% |
| 19 | $2.00 | 4,650 | $9K | 2.7% |
| 20 | $2.01 | 4,650 | $9K | 2.7% |
| 21 | $2.01 | 1,428 | $3K | 0.8% |
| 22 | $2.10 | 20,000 | $42K | 12.0% |
| 23 | $2.17 | 9,036 | $20K | 5.6% |
| 24 | $2.18 | 200 | $436 | 0.1% |
| Total | $1.97 avg | 178,080 | $350K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |